open access

Ahead of Print
ORIGINAL ARTICLES
Published online: 2019-04-03
Submitted: 2019-01-15
Accepted: 2019-03-01
Get Citation

Efficacy of erythropoietin pretreated mesenchymal stem cells in murine burn wound healing: possible in vivo transdifferentiation into keratinocytes

Reda Abdelnasser Imam, Ayman Abu-Elenein Rizk
DOI: 10.5603/FM.a2019.0038
·
Pubmed: 30949996

open access

Ahead of Print
ORIGINAL ARTICLES
Published online: 2019-04-03
Submitted: 2019-01-15
Accepted: 2019-03-01

Abstract

Background: Stem cells have shown promising potential to treat burn wounds. Erythropoietin was capable of promoting in vitro transdifferentiation of mesenchymal stem cells (MSCs). The aim of the study was to investigate possible role of erythropoietin pretreated mesenchymal stem cells (EPOa/MSCs) in burn wounds healing and to evaluate its in vivo differentiation into keratinocytes.

Materials and Methods: Forty rats were utilized in this study divided into 4 groups (n=10 for each). Control group (I), Burn group (II), Burn + MSCs, group (III), Burn + EPOa/MSCs. 1x106 Cells were injected locally for each 1 cm2 of burn areas. Burn areas were followed morphologically. After 21days of the experiment, the rats were euthanized, skin specimens were assessed biochemically, histologically and immunohistochemically.

Results: EPOa/MSCs had enhanced significantly (p<0.05) burn wound vimentin gene expression and level of IL-10 while decreased IL-1 and COX2 as compared to the burn group. Histologically, EPOa/MSCs had improved epithelialization despite stem cells differentiation into keratinocytes had been rarely detected by PKH26 red fluorescence. EPOa/MSCs had promoted angiogenesis as detected by significant increase in VEGF and PDGF immunoexpression as compared to burn group.

Conclusions: EPOa/MSCs might improve burn wound healing probably through anti-inflammatory, immunomodulatory and angiogenic action. However, in vivo trandifferentiation into keratinocytes had been rarely detected.

Abstract

Background: Stem cells have shown promising potential to treat burn wounds. Erythropoietin was capable of promoting in vitro transdifferentiation of mesenchymal stem cells (MSCs). The aim of the study was to investigate possible role of erythropoietin pretreated mesenchymal stem cells (EPOa/MSCs) in burn wounds healing and to evaluate its in vivo differentiation into keratinocytes.

Materials and Methods: Forty rats were utilized in this study divided into 4 groups (n=10 for each). Control group (I), Burn group (II), Burn + MSCs, group (III), Burn + EPOa/MSCs. 1x106 Cells were injected locally for each 1 cm2 of burn areas. Burn areas were followed morphologically. After 21days of the experiment, the rats were euthanized, skin specimens were assessed biochemically, histologically and immunohistochemically.

Results: EPOa/MSCs had enhanced significantly (p<0.05) burn wound vimentin gene expression and level of IL-10 while decreased IL-1 and COX2 as compared to the burn group. Histologically, EPOa/MSCs had improved epithelialization despite stem cells differentiation into keratinocytes had been rarely detected by PKH26 red fluorescence. EPOa/MSCs had promoted angiogenesis as detected by significant increase in VEGF and PDGF immunoexpression as compared to burn group.

Conclusions: EPOa/MSCs might improve burn wound healing probably through anti-inflammatory, immunomodulatory and angiogenic action. However, in vivo trandifferentiation into keratinocytes had been rarely detected.

Get Citation

Keywords

erythropoietin, stem cells, keratinocytes, burn-rats

About this article
Title

Efficacy of erythropoietin pretreated mesenchymal stem cells in murine burn wound healing: possible in vivo transdifferentiation into keratinocytes

Journal

Folia Morphologica

Issue

Ahead of Print

Published online

2019-04-03

DOI

10.5603/FM.a2019.0038

Pubmed

30949996

Keywords

erythropoietin
stem cells
keratinocytes
burn-rats

Authors

Reda Abdelnasser Imam
Ayman Abu-Elenein Rizk

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By  "Via Medica sp. z o.o." sp.k., Świętokrzyska 73, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl